|
|
|
Volumn 55, Issue 1, 1997, Pages 249-254
|
|
Major depression: Assessing the role of new antidepressants
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALPRAZOLAM;
ANTIARRHYTHMIC AGENT;
ANTIDEPRESSANT AGENT;
ASTEMIZOLE;
BENZODIAZEPINE;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
CARBAMAZEPINE;
FLECAINIDE ACETATE;
FLUOXETINE;
HALOPERIDOL;
HISMANA;
LITHIUM;
MONOAMINE OXIDASE INHIBITOR;
NEFAZODONE;
NEUROLEPTIC AGENT;
PAROXETINE;
PROPAFENONE;
QUINIDINE;
SEROTONIN UPTAKE INHIBITOR;
SERTRALINE;
TERFENADINE;
THIORIDAZINE;
TRIAZOLAM;
TRICYCLIC ANTIDEPRESSANT AGENT;
UNCLASSIFIED DRUG;
VENLAFAXINE;
DEPRESSION;
DRUG COST;
DRUG EFFICACY;
GASTROINTESTINAL TOXICITY;
HUMAN;
MENTAL DISEASE;
NEUROTOXICITY;
PSYCHOPHARMACOTHERAPY;
REVIEW;
SEROTONIN SYNDROME;
SEXUAL DYSFUNCTION;
VISUAL IMPAIRMENT;
XEROSTOMIA;
ANTIDEPRESSIVE AGENTS;
DEPRESSIVE DISORDER;
HUMANS;
|
|
EID: 0031030996
PISSN: 0002838X
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (8)
|
|
References (22)
|
